Date: 2014-11-18
Type of information: Nomination
Compound: vice-president
Company: Seattle Genetics (USA - WA)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On November 18, 2014, Seattle Genetics announced the appointment of Jean I. Liu, as General Counsel, Executive Vice President, Legal Affairs and Corporate Secretary. Ms. Liu brings more than 20 years of professional experience advising pharmaceutical and biotechnology companies on a broad range of corporate, intellectual property, compliance and general legal matters. She will report to Clay Siegall, President and Chief Executive Officer. Ms. Liu replaces Kirk Schumacher, who has been with Seattle Genetics since 2004 and is retiring.
- Prior to joining Seattle Genetics, Ms. Liu served since 2011 as Vice President and General Counsel at Halozyme, a publicly traded biotechnology company. Prior to Halozyme, from 1998 to 2011 she held a number of legal roles at Durect Corporation, most recently as Chief Legal Officer and Corporate Secretary. Ms. Liu’s early career included work at Pillsbury, Madison & Sutro (now Pillsbury Winthrop) and Venture Law Group where she focused on broad areas of legal advisory for early-stage companies, including technology transfer, licensing, patents, and copyright and trademark litigation. Ms. Liu obtained her B.S. in Cellular and Molecular Biology with highest distinction from the University of Michigan, her M.S. in Biology from Stanford University and her J.D. from Columbia University where she was a Harlan Fiske Stone Scholar.
Financial terms:
Latest news:
Is general: Yes
